F. Galateau-salle, G. Soit-ilg, A. , L. Stang, N. Brochard et al., The French mesothelioma network from, Ann Pathol, 1998.
URL : https://hal.archives-ouvertes.fr/inserm-00995995

N. Ordonez, Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases, Modern Pathology, vol.21, issue.3, pp.373-83, 2006.
DOI : 10.1038/modpathol.3800067

F. Galateau-salle, R. Attanoos, A. Gibbs, L. Burke, P. Astoul et al., Lymphohistiocytoid Variant of Malignant Mesothelioma of the Pleura: A Series of 22 Cases, The American Journal of Surgical Pathology, vol.31, issue.5, pp.711-717, 2007.
DOI : 10.1097/PAS.0b013e31802baad7

. Patho&co, Available from: http://alf3.urz.unibas.ch/pathopic/getpic fra.cfm?id=005900)

F. Thivolet-béjui, Tumeurs de la plèvre. Lyon2008; Available from

W. Travis, E. Brambilla, H. Müller-hermelink, and C. Harris, Tumours of the pleura. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, 2004.

V. Shankar, Soft Tissue PathologyOutlines.com, Inc.; 2003-2014; Available from

B. Addis and H. Roche, Problems in mesothelioma diagnosis, Histopathology, vol.48, issue.1, 2009.
DOI : 10.1111/j.1365-2559.2008.03178.x

F. Galateau-salle, J. Vignaud, L. Burke, A. Gibbs, E. Brambilla et al., Well-differentiated Papillary Mesothelioma of the Pleura, The American Journal of Surgical Pathology, vol.28, issue.4, pp.534-574, 2004.
DOI : 10.1097/00000478-200404000-00013

L. Stang, N. Belot, A. , G. Soit-ilg, A. Rolland et al., Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005, International Journal of Cancer, vol.26, issue.1, pp.232-240, 1980.
DOI : 10.1002/ijc.24711

URL : https://hal.archives-ouvertes.fr/hal-00698003

. Inca, Amiante et mésothéliome pleural malin Institut National du Cancer. [Prévention], 2012.

P. Grosclaude, N. Bossard, L. Remontet, A. Belot, P. Arveux et al., Survie des patients atteints de cancer en France, 2007.
DOI : 10.1007/978-2-287-39310-5

URL : https://hal.archives-ouvertes.fr/hal-00434568

J. Wagner, C. Sleggs, and P. Marchand, Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province, Occupational and Environmental Medicine, vol.17, issue.4, pp.260-71, 1960.
DOI : 10.1136/oem.17.4.260

J. Goodman, M. Nascarella, and P. Valberg, Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control, pp.1237-54, 2009.

J. Hofmann, D. Mintzer, and M. Warhol, Malignant mesothelioma following radiation therapy, The American Journal of Medicine, vol.97, issue.4, pp.379-82, 1994.
DOI : 10.1016/0002-9343(94)90307-7

A. Farioli, F. Violante, S. Mattioli, S. Curti, and D. Kriebel, Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control, pp.1535-1580, 2013.

L. Chirieac, J. Barletta, B. Yeap, W. Richards, T. Tilleman et al., Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma Postirradiation malignant mesothelioma. Cancer, J Clin Oncol, vol.3177, issue.109, pp.4544-91379, 1996.

F. Vandenbos, M. Figueredo, M. Dumon-gubeno, I. Nicolle, A. Tarhini et al., M??soth??liome pleural malin apr??s irradiation pour maladie de Hodgkin, Revue de Pneumologie Clinique, vol.69, issue.5, pp.291-294, 2013.
DOI : 10.1016/j.pneumo.2013.04.004

S. Kashanskiy and A. N. , Paediatric mesothelioma: is there the such a disease?]. Bull Cancer, pp.571-577, 2010.

C. Rosas-salazar, S. Gunawardena, and J. Spahr, Malignant pleural mesothelioma in a child with ataxia-telangiectasia. Pediatr Pulmonol, pp.94-101, 2013.

A. Sugalski, M. Davis, L. Prasannan, V. Saldivar, J. Hung et al., Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child. Pediatr Blood Cancer Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child, Hum Pathol. 2013, vol.6044, issue.14, pp.664-673, 2013.

G. Grundy and R. Miller, Malignant mesothelioma in childhood Report of 13 cases. Cancer, pp.1216-1224, 1972.

A. Fraire, S. Cooper, S. Greenberg, P. Buffler, C. Langston et al., Mesothelioma of childhood. Cancer Pleural mesothelioma in a young male patient. Monaldi Archives for Chest isease, pp.838-4796, 1988.

J. Peto, A. Decarli, L. Vecchia, C. Levi, F. Negri et al., The European mesothelioma epidemic, British Journal of Cancer, vol.79, issue.3/4, pp.3-4666, 1999.
DOI : 10.1038/sj.bjc.6690105

R. Spirtas, E. Heineman, L. Bernstein, G. Beebe, R. Keehn et al., Malignant mesothelioma: attributable risk of asbestos exposure., Occupational and Environmental Medicine, vol.51, issue.12, 1994.
DOI : 10.1136/oem.51.12.804

A. Chevalier, S. Ducamp, G. Soit-ilg, A. Goldberg, M. Goldberg et al., Des indicateurs en santé du Travail-Risques professionnels dus à l'amiante. wwwinvssantefr [serial on the Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health, Dtsch Arztebl Int, vol.110, issue.18, pp.319-345, 2013.

J. Leigh, P. Davidson, L. Hendrie, and D. Berry, Malignant mesothelioma in Australia, 1945-2000, American Journal of Industrial Medicine, vol.41, issue.3, pp.188-201, 1945.
DOI : 10.1002/ajim.10047

M. Carbone, B. Ly, R. Dodson, I. Pagano, P. Morris et al., Malignant mesothelioma: Facts, Myths, and Hypotheses, Journal of Cellular Physiology, vol.57, issue.1, pp.44-58, 2009.
DOI : 10.1002/jcp.22724

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143206

T. Burki, Health experts concerned over India's asbestos industry, The Lancet, vol.375, issue.9715, pp.626-633, 2010.
DOI : 10.1016/S0140-6736(10)60251-6

P. Godard, B. Housset, B. Crestani, C. Marquette, A. Scherpereel et al., Recommandations de la Société Française de Pneumologie de Langue Française sur le mésothéliome pleural-Conférence d'experts, Rev Mal Respir, 2006.

N. Merritt, C. Blewett, J. Miller, W. Bennett, J. Young et al., Survival after conservative (palliative) management of pleural malignant mesothelioma, Journal of Surgical Oncology, vol.12, issue.3, pp.171-175, 2001.
DOI : 10.1002/jso.1143

J. Edwards, K. Abrams, J. Leverment, T. Spyt, D. Waller et al., Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems, Thorax, vol.55, issue.9, pp.731-736, 2000.
DOI : 10.1136/thorax.55.9.731

J. Peto, J. Hodgson, F. Matthews, and J. Jones, Continuing increase in mesothelioma mortality in Britain, The Lancet, vol.345, issue.8949, pp.535-544, 1995.
DOI : 10.1016/S0140-6736(95)90462-X

J. Hodgson and A. Darnton, The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure, The Annals of Occupational Hygiene, vol.44, issue.8, pp.565-601, 2000.
DOI : 10.1016/S0003-4878(00)00045-4

D. Kamp, Asbestos-induced lung diseases: an update, Translational Research, vol.153, issue.4, 2009.
DOI : 10.1016/j.trsl.2009.01.004

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544481

A. Lee, D. Raz, B. He, and D. Jablons, Update on the molecular biology of malignant mesothelioma. Cancer, Apr, vol.15109, issue.8, pp.1454-61, 2007.

N. Heintz, Y. Janssen-heininger, B. Mossman, T. Colby, P. Cagle et al., Asbestos, Lung Cancers, and Mesotheliomas, American Journal of Respiratory Cell and Molecular Biology, vol.42, issue.2, pp.133-142, 2000.
DOI : 10.1165/rcmb.2009-0206TR

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822975

K. Antman, R. Ruxer, J. Aisner, J. Vawter, and G. , Mesothelioma following Wilms' tumor in childhood. Cancer, Jul, vol.1554, issue.2, pp.367-376, 1984.

D. Hodgson, E. Gilbert, G. Dores, S. Schonfeld, C. Lynch et al., Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.25, issue.12, pp.1489-97, 2007.
DOI : 10.1200/JCO.2006.09.0936

M. Carbone and H. Pass, Evolving Aspects of Mesothelioma Carcinogenesis: SV40 and Genetic Predisposition, Journal of Thoracic Oncology, vol.1, issue.2, pp.169-71, 2006.
DOI : 10.1016/S1556-0864(15)31534-3

B. Burmeister, T. Schwerdtle, I. Poser, E. Hoffmann, A. Hartwig et al., Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.558, issue.1-2, pp.81-92, 2004.
DOI : 10.1016/j.mrgentox.2003.11.003

J. Manfredi, J. Dong, W. Liu, L. Resnick-silverman, R. Qiao et al., Evidence against a Role for SV40 in Human Mesothelioma, Cancer Research, vol.65, issue.7, pp.2602-2611, 2005.
DOI : 10.1158/0008-5472.CAN-04-2461

N. Shivapurkar, T. Wiethege, I. Wistuba, S. Milchgrub, K. Muller et al., Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas, International Journal of Cancer, vol.58, issue.5, pp.743-748, 2000.
DOI : 10.1002/(SICI)1097-0215(20000301)85:5<743::AID-IJC24>3.0.CO;2-3

M. Huncharek, Non-asbestos related diffuse malignant mesothelioma. Tumori, 2002.

V. Ascoli, E. Romeo, C. Scalzo, C. Cozzi, I. Ancona et al., Familial malignant mesothelioma: A population-based study in Central Italy Cancer Epidemiol Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer, pp.157-69, 1980.

C. Parker, E. Neville, P. Astoul, P. Baas, T. Berghmans et al., Lung cancer * 8: Management of malignant mesothelioma of Thoracic Surgeons for the management of malignant pleural mesothelioma, Thorax. Eur Respir J, vol.5835, issue.93, pp.809-13479, 2003.

A. Musk, N. Olsen, H. Alfonso, A. Reid, R. Mina et al., Predicting survival in malignant mesothelioma, European Respiratory Journal, vol.38, issue.6, pp.1420-1424, 2011.
DOI : 10.1183/09031936.00000811

K. Kadota, K. Suzuki, C. Colovos, C. Sima, V. Rusch et al., A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma, Modern Pathology, vol.15, issue.2, pp.260-71, 2012.
DOI : 10.1158/0008-5472.CAN-09-3993

J. Sussman and J. Rosai, Lymph Node Metastasis, The American Journal of Surgical Pathology, vol.14, issue.9, pp.819-847, 1990.
DOI : 10.1097/00000478-199009000-00003

M. Sheaff, Should cytology be an acceptable means of diagnosing malignant mesothelioma? Cytopathology, 2011.

A. Husain, T. Colby, N. Ordonez, T. Krausz, R. Attanoos et al., Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group, Archives of Pathology & Laboratory Medicine, vol.137, issue.5, pp.647-67, 2013.
DOI : 10.5858/arpa.2012-0214-OA

R. Bueno, J. Reblando, J. Glickman, M. Jaklitsch, J. Lukanich et al., Pleural Biopsy: A Reliable Method for Determining the Diagnosis But Not Subtype in Mesothelioma, The Annals of Thoracic Surgery, vol.78, issue.5, pp.1774-1780, 2004.
DOI : 10.1016/j.athoracsur.2004.05.007

T. Crotty, J. Myers, A. Katzenstein, H. Tazelaar, S. Swensen et al., Localized Malignant Mesothelioma, The American Journal of Surgical Pathology, vol.18, issue.4, pp.357-63, 1994.
DOI : 10.1097/00000478-199404000-00004

D. Henderson, G. Reid, S. Kao, N. Van-zandwijk, and S. Klebe, Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA, Journal of Clinical Pathology, vol.14, issue.Suppl. 1, 2013.
DOI : 10.1136/jclinpath-2013-201609

S. Matsukuma, S. Aida, Y. Hata, Y. Sugiura, and S. Tamai, Localized malignant peritoneal mesothelioma containing rhabdoid cells, Pathology International, vol.18, issue.5, pp.389-91, 1996.
DOI : 10.1111/j.1440-1827.1996.tb03627.x

L. Puttagunta, R. Vriend, and G. Nguyen, Deciduoid Epithelial Mesothelioma of the Pleura With Focal Rhabdoid Change, The American Journal of Surgical Pathology, vol.24, issue.10, pp.1440-1443, 2000.
DOI : 10.1097/00000478-200010000-00021

C. Santos, F. Gamboa, F. Fradinho, A. Pego, L. Carvalho et al., Deciduoid pleural mesothelioma ??? A rare entity in a young woman, Revista Portuguesa de Pneumologia (English Edition), vol.18, issue.6, pp.294-302, 2012.
DOI : 10.1016/j.rppnen.2012.03.002

L. Brcic, M. Jakopovic, I. Brcic, V. Klaric, M. Milosevic et al., Reproducibility of histological subtyping of malignant pleural mesothelioma. Virchows Arch, 2014.

F. Galateau-salle, M. Copin, A. Delajartre, J. Vignaud, P. Astoul et al., Which criteria for the anatomopathologic diagnosis of malignant pleural mesothelioma?]. Rev Mal Respir, pp.11-37, 2006.

S. Hammar, D. Bockus, F. Remington, and K. Rohrbach, Mucin-Positive Epithelial Mesotheliomas: A Histochemical, Immunohistochemical, and Ultrastructural Comparison with Mucin-Producing Pulmonary Adenocarcinomas, Ultrastructural Pathology, vol.20, issue.4, pp.293-325, 1996.
DOI : 10.3109/01913129609016331

H. Yaziji, H. Battifora, T. Barry, H. Hwang, C. Bacchi et al., Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity, Modern Pathology, vol.19, issue.4, pp.514-537, 2006.
DOI : 10.1038/modpathol.3800534

S. Klebe, N. Brownlee, A. Mahar, J. Burchette, T. Sporn et al., Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas, Am J Surg Pathol, vol.2335, issue.7712, pp.470-91823, 2010.

R. Mcmillan, M. Zauderer, M. Bott, and M. Ladanyi, Important recent insights into the genetics and biology of malignant pleural mesothelioma. Ann Cardiothorac Surg, pp.462-467, 2012.

M. Bott, M. Brevet, B. Taylor, S. Shimizu, T. Ito et al., The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma, Nature Genetics, vol.3, issue.7, pp.668-72, 2011.
DOI : 10.1186/gb-2007-8-11-r232

J. Testa, M. Cheung, P. J. Below, J. Tan, Y. Sementino et al., Germline BAP1 mutations predispose to malignant mesothelioma Welldifferentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation, Nat Genet Ann Oncol, vol.4324, issue.818, pp.1022-52147, 2011.

M. Ladanyi, M. Zauderer, L. Krug, T. Ito, R. Mcmillan et al., New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment, Clinical Cancer Research, vol.18, issue.17, pp.4485-90, 2012.
DOI : 10.1158/1078-0432.CCR-11-2375

Y. Yoshikawa, A. Sato, T. Tsujimura, M. Emi, T. Morinaga et al., Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma, Cancer Science, vol.29, issue.5, pp.868-74
DOI : 10.1111/j.1349-7006.2012.02223.x

L. De-assis, J. Locatelli, and M. Isoldi, The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1845, issue.2, 2014.
DOI : 10.1016/j.bbcan.2014.01.008

T. Mizuno, H. Murakami, M. Fujii, F. Ishiguro, I. Tanaka et al., YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes, Oncogene, vol.25, issue.49, pp.5117-5139, 2012.
DOI : 10.1038/onc.2012.5

D. Jean, J. Daubriac, L. Pimpec-barthes, F. Galateau-salle, F. Jaurand et al., Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment, Archives of Pathology & Laboratory Medicine, vol.136, issue.3, pp.277-93, 2012.
DOI : 10.5858/arpa.2011-0215-RA

G. Levallet, M. Vaisse-lesteven, L. Stang, N. Ilg, A. Brochard et al., Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group, Journal of Thoracic Oncology, vol.7, issue.3, pp.599-606, 2012.
DOI : 10.1097/JTO.0b013e3182417da5

Y. Sekido, Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci, pp.1-6, 2010.

P. Illei, V. Rusch, M. Zakowski, and M. Ladanyi, Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res, pp.2108-2121, 2003.

L. Wong, J. Zhou, D. Anderson, and R. Kratzke, Inactivation of p16INK4a expression in malignant mesothelioma by methylation. Lung Cancer, pp.131-137, 2002.

M. Ladanyi, Implications of P16/CDKN2A deletion in pleural mesotheliomas. Lung Cancer, pp.95-103, 2005.

H. Hwang, C. Tse, S. Rodriguez, A. Gown, and A. Churg, p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma, The American Journal of Surgical Pathology, vol.38, issue.5, pp.681-689, 2014.
DOI : 10.1097/PAS.0000000000000176

D. Wu, K. Hiroshima, S. Matsumoto, K. Nabeshima, T. Yusa et al., Diagnostic Usefulness of p16/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis, American Journal of Clinical Pathology, vol.139, issue.1, pp.39-46, 2013.
DOI : 10.1309/AJCPT94JVWIHBKRD

S. Chiosea, A. Krasinskas, P. Cagle, K. Mitchell, D. Zander et al., Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas, Modern Pathology, vol.54, issue.6, pp.742-749, 2008.
DOI : 10.1158/1078-0432.CCR-04-1884

M. Takeda, T. Kasai, Y. Enomoto, M. Takano, K. Morita et al., 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis, Pathology International, vol.23, issue.5, pp.395-404, 2010.
DOI : 10.1111/j.1440-1827.2010.02534.x

S. Dacic, H. Kothmaier, S. Land, Y. Shuai, I. Halbwedl et al., Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch, pp.627-662, 2008.

M. Lo-iacono, V. Monica, L. Righi, F. Grosso, R. Libener et al., Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study, Journal of Thoracic Oncology, vol.10, issue.3, 2014.
DOI : 10.1097/JTO.0000000000000436

J. Brenner, P. Sordillo, G. Magill, and R. Golbey, Malignant mesothelioma of the pleura: Review of 123 patients, Cancer, vol.42, issue.11, pp.2431-2436, 1982.
DOI : 10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W

K. Anderson, W. Hurley, B. Hurley, and D. Ohrt, Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer, Jul, vol.1556, issue.2, pp.273-279, 1985.

N. André, S. Kashanskiy, and A. Agaimy, Pediatric Pleural Mesothelioma, 2012.
DOI : 10.1007/978-3-642-04197-6_27

D. Bruin, M. Burgers, J. Baas, P. Van-'t, M. Veer et al., Malignant mesothelioma after radiation treatment for Hodgkin lymphoma, Blood, vol.113, issue.16, pp.3679-81, 2009.
DOI : 10.1182/blood-2008-10-184705

L. Weissmann, J. Corson, A. Neugut, and K. Antman, Malignant mesothelioma following treatment for Hodgkin's disease., Journal of Clinical Oncology, vol.14, issue.7, pp.2098-100, 1996.
DOI : 10.1200/JCO.1996.14.7.2098

J. Shia, J. Qin, R. Erlandson, R. King, P. Illei et al., Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases, Virchows Archiv, vol.52, issue.5, pp.828-862, 2005.
DOI : 10.1007/s00428-005-0035-y

F. Demirag, E. Unsal, A. Yilmaz, and A. Caglar, Prognostic Significance of Vascular Endothelial Growth Factor, Tumor Necrosis, and Mitotic Activity Index in Malignant Pleural Mesothelioma, Chest, vol.128, issue.5, pp.3382-3389, 2005.
DOI : 10.1378/chest.128.5.3382